Symposium on risks to bystanders in clinical research: an introduction

Gelijkaardige items

• Risk to bystanders in clinical trials: a symposium
  door: Eyal, Nir
  Gepubliceerd in: (2019)
• Regulating impact on bystanders in clinical trials: an unsettled frontier
  door: Eyal, Nir, et al.
  Gepubliceerd in: (2019)
• The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction
  door: Eyal, Nir
  Gepubliceerd in: (2017)
• Ethical Complexities of Responding to Bystander Risk in HIV Prevention Trials
  door: Eyal, Nir, et al.
  Gepubliceerd in: (2019)
• Invited Commentary on Dubé et al. (Perceptions of Equipoise, Risk/Benefit Ratios, and “Otherwise Healthy Volunteers” in the Context of Early-Phase HIV Cure Research in the United States—A Qualitative Inquiry): Are HIV-Infected Candidates for Participation in Risky Cure-Related Studies Otherwise Healthy?
  door: Eyal, Nir, et al.
  Gepubliceerd in: (2017)